This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Mar 22;115(3):194-195.

doi: 10.1093/qjmed/hcac019.

Safety cannot justify the use of ivermectin for the management of COVID-19

J Deng¹, K Heybati², W Hou¹, Q K Zuo^{3

4}

Affiliations

Affiliations

¹ From the Faculty of Health Sciences, McMaster University, 1280 Main St W, Hamilton, ON L8S 4L8, Canada.
² Mayo Clinic Alix School of Medicine, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA.
³ Department of Anesthesiology, Rutgers New Jersey Medical School, 185 S Orange Ave, Newark, NJ 07103, USA.
⁴ Faculty of Science, McGill University, 845 Sherbrooke St W, Montreal, QC H3A 0G5, Canada.

PMID: 35080630
DOI: 10.1093/qjmed/hcac019

Comment

Safety cannot justify the use of ivermectin for the management of COVID-19

J Deng et al. QJM. 2022.

. 2022 Mar 22;115(3):194-195.

doi: 10.1093/qjmed/hcac019.

Authors

J Deng¹, K Heybati², W Hou¹, Q K Zuo^{3

4}

Affiliations

¹ From the Faculty of Health Sciences, McMaster University, 1280 Main St W, Hamilton, ON L8S 4L8, Canada.
² Mayo Clinic Alix School of Medicine, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA.
³ Department of Anesthesiology, Rutgers New Jersey Medical School, 185 S Orange Ave, Newark, NJ 07103, USA.
⁴ Faculty of Science, McGill University, 845 Sherbrooke St W, Montreal, QC H3A 0G5, Canada.

PMID: 35080630
DOI: 10.1093/qjmed/hcac019

No abstract available

PubMed Disclaimer

Comment on

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. Caly L, et al. Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3. Antiviral Res. 2020. PMID: 32251768 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems